Putnam Investments LLC Amgen Inc Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Putnam Investments LLC holds 126,091 shares of AMGN stock, worth $32.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

126,091

Previous 146,256 13.79%

Holding current value

$32.7 Million

Previous $39.3 Million 7.61%

% of portfolio

0.05%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $5.16 Million - $5.82 Million	-20,165 Reduced 13.79%	126,091 $36.3 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $759,590 - $943,052	3,474 Added 2.43%	146,256 $39.3 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $77.2 Million - $91.3 Million	-360,447 Reduced 71.63%	142,782 $31.7 Million
Q1 2023 May 22, 2023	SELL	$225.79 - $275.2 $39.1 Million - $47.6 Million	-173,029 Reduced 25.59%	503,229 $122 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $2.33 Million - $2.97 Million	-10,191 Reduced 1.48%	676,258 $178 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $13.5 Million - $15.3 Million	60,352 Added 9.64%	686,449 $155 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $7.14 Million - $7.94 Million	-30,938 Reduced 4.71%	626,097 $152 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $6.81 Million - $7.53 Million	31,052 Added 4.96%	657,035 $159 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $7.63 Million - $8.74 Million	-38,381 Reduced 5.78%	625,983 $141 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $3.99 Million - $4.68 Million	18,805 Added 2.91%	664,364 $141 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $301 Million - $334 Million	-1,288,563 Reduced 66.62%	645,559 $157 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $6.05 Million - $7.05 Million	-27,255 Reduced 1.39%	1,934,122 $481 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.73 Million - $2.06 Million	7,978 Added 0.41%	1,961,377 $451 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $38.7 Million - $43 Million	-164,769 Reduced 7.78%	1,953,399 $496 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $3.55 Million - $4.36 Million	-17,948 Reduced 0.84%	2,118,168 $500 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $23.5 Million - $31.2 Million	-129,100 Reduced 5.7%	2,136,116 $433 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $38.5 Million - $49.5 Million	203,549 Added 9.87%	2,265,216 $546 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $36.7 Million - $43.9 Million	210,594 Added 11.38%	2,061,667 $399 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $25.3 Million - $29.7 Million	151,910 Added 8.94%	1,851,073 $341 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $197,329 - $222,433	1,091 Added 0.06%	1,699,163 $323 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.29 Million - $1.51 Million	7,235 Added 0.43%	1,698,072 $331 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $6.15 Million - $6.94 Million	-33,213 Reduced 1.93%	1,690,837 $350 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $5.29 Million - $5.95 Million	31,875 Added 1.88%	1,724,050 $318 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $35.3 Million - $41.3 Million	-208,503 Reduced 10.97%	1,692,175 $288 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $34.5 Million - $38.5 Million	204,371 Added 12.05%	1,900,678 $331 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $284 Million - $324 Million	1,696,307	1,696,307 $316 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Amgen Inc Transaction History